CDC Report: Emergency Room Diagnoses for Severe Marijuana-Related Vomiting Illness Spike
#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to recognize Cannabis Hyperemesis Syndrome as an increasingly common presentation in emergency departments, as rising THC potency in modern cannabis products is driving higher rates of severe, refractory nausea and vomiting that may be misdiagnosed as other gastrointestinal disorders. Patients who use cannabis regularly should be counseled about this dose-dependent risk, and providers should specifically ask about cannabis use when evaluating recurrent vomiting to enable appropriate diagnosis and potentially avoid unnecessary gastroenterology workups or opioid prescriptions. The spike in CHS cases reflects a critical need for clinical education about this syndrome given the changing landscape of cannabis potency and legalization.
Cannabis hyperemesis syndrome (CHS) represents an increasingly recognized clinical entity with rising emergency department presentations, as documented by recent CDC surveillance data showing a spike in severe marijuana-related vomiting illness diagnoses. CHS occurs in patients with chronic, frequent cannabis use and is characterized by severe cyclic vomiting, abdominal pain, and nausea that paradoxically improve with hot showers, distinguishing it from other causes of hyperemesis. The syndrome’s emergence correlates with increased THC potency and cannabinoid concentrations in modern cannabis products, suggesting a dose-response relationship that clinicians should consider when taking substance use histories. Recognition of CHS is critical for emergency medicine and primary care physicians, as misdiagnosis may lead to unnecessary costly investigations and delayed symptom resolution through cannabis cessation. Clinicians should maintain heightened awareness of CHS in patients presenting with recurrent, unexplained severe vomiting and a history of regular cannabis use, particularly heavy or long-term use. For patients experiencing this condition, counseling about the dose-dependent nature of CHS risk and the potential benefits of reducing cannabis consumption or switching to lower-potency products may help prevent recurrent emergency visits and improve outcomes.
“What we’re seeing in emergency departments aligns with what my colleagues and I have observed clinically over the past decade: cannabinoid hyperemesis syndrome is a real and underrecognized consequence of chronic, high-potency cannabis use, particularly as THC concentrations in available products have increased substantially. The CDC data here helps quantify what was anecdotal before, though we still need prospective studies to understand individual risk factors and whether product potency thresholds matter. This should prompt us to counsel frequent users about this risk during routine visits, not to discourage cannabis use categorically, but to ensure informed decision-making.”
🚑 The recent spike in emergency department visits for cannabis hyperemesis syndrome warrants clinical awareness, though distinguishing CHS from other causes of severe vomiting requires careful history-taking around cannabis use patterns and symptom timing relative to use. The increasing potency of modern cannabis products—particularly high-THC concentrates—likely contributes to rising case numbers, but confounding factors such as improved recognition and reporting by clinicians, changing patterns of product use (edibles versus smoking), and evolving patient demographics may also explain the trend. While the underlying mechanism of CHS remains incompletely understood and cannabinoid receptor involvement is suspected, no high-quality prospective studies definitively establish causation or define risk thresholds for vulnerable users. Clinicians encountering patients with recurrent severe vomiting, especially those reporting cannabis use, should screen specifically for CHS and consider cessation as both diagnostic and therapeutic; however, management remains largely supportive
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
